Skip to main content
SpringerLink
Log in

PYP or DPD and HDP for cardiac amyloidosis one for all, all for one

  • Letter to the Editor
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Lee JC, Alipour R. Hydroxymethylene disphosphonate for imaging transthyretin cardiac amyloidosis. J Nuclear Cardiol (2019)

  2. Cappelli F, Gallini C, Di Mario C, Costanzo EN, Vaggelli L, Tutino F, Ciaccio A, Bartolini S, Angelotti P, Frusconi S, Farsetti S, Vergaro G, Giorgetti A, Marzullo P, Genovesi D, Emdin M, Perfetto F. Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis. J Nucl Cardiol. 2019;26(2):497–504. https://doi.org/10.1007/s12350-017-0922-z.

    Article  PubMed  Google Scholar 

  3. Yang JC, Fox J, Chen C, Yu AF. Cardiac ATTR amyloid nuclear imaging-not all bone scintigraphy radionuclide tracers are created equal. J Nucl Cardiol. 2018;25(5):1879–84. https://doi.org/10.1007/s12350-017-1141-3.

    Article  PubMed  Google Scholar 

  4. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–12.

    Article  CAS  Google Scholar 

  5. Cappelli F, Gallini C, Costanzo EN, Tutino F, Ciaccio A, Vaggelli L, Bartolini S, Morini S, Martone R, Angelotti P, Frusconi S, Di Mario C, Perfetto F. Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon. Int J Cardiol. 2018;1(254):346–50. https://doi.org/10.1016/j.ijcard.2017.10.027.

    Article  Google Scholar 

  6. Hutt DF, Fontana M, Burniston M, Quigley AM, Petrie A, Ross JC, Page J, Martinez-Naharro A, Wechalekar AD, Lachmann HJ, Quarta CC, Rezk T, Mahmood S, Sachchithanantham S, Youngstein T, Whelan CJ, Lane T, Gilbertson JA, Rowczenio D, Hawkins PN, Gillmore JD. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid. Eur Heart J Cardiovasc Imaging. 2017;18(12):1344–50. https://doi.org/10.1093/ehjci/jew325.

    Article  PubMed  Google Scholar 

  7. Sperry BW, Gonzalez MH, Brunken R, Cerqueira MD, Hanna M, Jaber WA. Non-cardiac uptake of technetium-99m pyrophosphate in transthyretin cardiac amyloidosis. J Nucl Cardiol. 2018;1:2–3. https://doi.org/10.1007/s12350-017-1166-7.

    Article  Google Scholar 

Download references

Disclosure

The authors Francesco Cappelli, Chiara Gallini and Federico Perfetto declare that they have no conflict of interest to disclose.

Author information

Authors and Affiliations

  1. Tuscan Regional Amyloid Center, Careggi University Hospital, Florence, Italy

    Francesco Cappelli MD & Federico Perfetto MD, PhD

  2. Interventional Structural Cardiology Division, Careggi University Hospital, Florence, Italy

    Francesco Cappelli MD

  3. Nuclear Medicine Division, Careggi University Hospital, Florence, Italy

    Chiara Gallini MD, PhD

Authors
  1. Francesco Cappelli MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chiara Gallini MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Federico Perfetto MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Francesco Cappelli MD.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cappelli, F., Gallini, C. & Perfetto, F. PYP or DPD and HDP for cardiac amyloidosis one for all, all for one. J. Nucl. Cardiol. 27, 1041–1042 (2020). https://doi.org/10.1007/s12350-019-01728-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-019-01728-6

Search

Navigation